Call Options Transactions Made in Q2 2025 in Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV) during Q2 2025. The information is specifically focused on institutions that hold call options of KalVista Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
400KNew |
$4.13M - $5.9M
|
400K
$4.9M
|
|
|
Aug 14, 2025
Q2 2025
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
143KNew |
$1.47M - $2.11M
|
143K
$1.75M
|
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
79.9K+ 159.8% |
$825K - $1.18M
|
130K
$1.59M
|
|
|
Aug 14, 2025
Q2 2025
|
Barclays PLC
London, X0 |
BUY
|
CALL |
50.8KNew |
$524K - $750K
|
50.8K
$622K
|
|
|
Aug 13, 2025
Q2 2025
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
21.4KNew |
$221K - $316K
|
21.4K
$262K
|
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-66.8K- 19.8% |
$689K - $986K
|
271K
$3.31M
|